Sort   by:  
 Page size 
UnknownIntravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.
Not available
S-EPMC2568005 | biostudies-literature
UnknownOutcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
Not available
S-EPMC5146706 | biostudies-literature
TranscriptomicsArray results for differential gene expression in 661W, a mouse cone photoreceptor-derived cell line, comparing cells incubated with vehicle controls vs. those treated with either of two 7-dehdyrocholesterol-derived oxysterols or cholesterol
RELEVANCE: Smith-Lemli-Opitz syndrome (SLOS) is a human disease caused by mutations in the gene coding for the enzyme DHCR7 (7-dehydrocholesterol (7DHC) reductase), which catalyzes the final step of cholesterol biosynthesis. Accumulated 7DHC in tissues and body fluids of SLOS patients gives rise t...
ORGANISM(S): Mus musculus 
2021-03-20 | E-MTAB-10055 | biostudies-arrayexpress
TranscriptomicsEngineering topology and kinetics of sucrose metabolism in Saccharomyces cerevisiae for improved ethanol yield
Sucrose is a major carbon source for industrial bioethanol production by Saccharomyces cerevisiae. In yeasts, two modes of sucrose metabolism occur: (i) extracellular hydrolysis by invertase, followed by uptake and metabolism of glucose and fructose, and (ii) uptake via sucrose-H+ symport followed b...
ORGANISM(S): Saccharomyces cerevisiae 
2011-09-05 | E-GEOD-30535 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of yeast under conditions of ammonium, L-alanine or L-glutamine limitation
Response of Saccharomyces cerevisiae to Ammonium, L-alanine, or L-glutamine Limitation. The protrotophic laboratory strain CEN.PK113-7D (MAT a) was grown in laboratory fermentors with a working volume of 1 litre at dilution rate (D) of 0.20 per hour (in triplicate for each nitrogen limited condition...
ORGANISM(S): Saccharomyces cerevisiae 
2006-06-13 | E-MEXP-724 | biostudies-arrayexpress
ProteomicsOff-target profiling of several PARP inhibitors using immobilized Niraparib beads
Explore additional off-targets of several PARP inhibitors using Niraparib beads
ORGANISM(S): Homo sapiens (Human) 
2025-05-06 | PXD044330 | Pride
Niraparib Parp Talazoparib Olaparib 
ProteomicsComprehensive selectivity profile of PARP inhibitors using kinobeads
Explore kinase off-targets of several PARP inhibitors using kinobeads
ORGANISM(S): Homo sapiens (Human) 
2025-05-06 | PXD045297 | Pride
Kinobeads Niraparib Parp Talazoparib Olaparib 
TranscriptomicsTranscription profiling of yeast grown in fermentors at different dilution rates
the protrotophic laboratory strain CEN.PK113-7D (MAT a) was grown in laboratory fermentors with a working volume of 1 litre at dilution rates of 0.02, 0.05, 0.10 (in triplicate), 0.20 (in triplicate), 0.25, and 0.33 per hour (in triplicate). At steady state, samples from each of the 12 continuous cu...
ORGANISM(S): Saccharomyces cerevisiae 
2022-11-21 | E-MEXP-593 | biostudies-arrayexpress
UnknownImprovement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study.
Not available
S-EPMC7839589 | biostudies-literature
UnknownCell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides.
Not available
S-EPMC10632401 | biostudies-literature
Sort   by:  
 Page size